4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-015766
EVP & Chief Commercial Officer gave up 824 shares (to pay taxes)
- EVP & Chief Commercial Officer acquired 11,087 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Harris Erik · EVP & Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-01 | Grant or award : show line 1 in the form | +7,800 | 22,109 | D | ||
| 2020-03-01 | Grant or award : show line 2 in the form | +3,287 | 25,396 | D | ||
| 2020-03-01 | Shares withheld for taxes : show line 3 in the form | −824 | $56.08 | $46,210 | 24,572 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-03-01 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +22,000 | $56.08 | 2030-03-01 | 22,000 | 22,000 | D |
Loading xslF345X03/doc4.xml…